Tirzepatide belongs to the dual GIP and GLP-1 receptor agonist class, offering a unique approach to blood sugar control and weight management. By activating these receptors, tirzepatide helps regulate glucose levels, reduces appetite, and extends the feeling of fullness after meals.*
  • Lowers A1C Levels

  • Helps you feel full faster, longer

  • Helps the body remove excess sugar from the blood

One subcutaneous injection weekly as directed by your Healthcare provider

Common side effects with Tirzepatide include:

  • Redness & itching at the injection site

  • Loss of appetite

  • Tiredness

  • Nausea

  • Upset stomach

  • Diarrhea, or constipation may occur

*Tirzepatide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate